358 related articles for article (PubMed ID: 19907295)
1. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
Erkanli L; Akova YA; Guney-Tefekli E; Tugal-Tutkun I
Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295
[TBL] [Abstract][Full Text] [Related]
2. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
3. Scleritis therapy.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and visual outcomes of Japanese patients with scleritis.
Keino H; Watanabe T; Taki W; Nakashima C; Okada AA
Br J Ophthalmol; 2010 Nov; 94(11):1459-63. PubMed ID: 20576778
[TBL] [Abstract][Full Text] [Related]
5. Smoking delays the response to treatment in episcleritis and scleritis.
Boonman ZF; de Keizer RJ; Watson PG
Eye (Lond); 2005 Sep; 19(9):949-55. PubMed ID: 15543188
[TBL] [Abstract][Full Text] [Related]
6. Severity of episcleritis and systemic disease association.
Akpek EK; Uy HS; Christen W; Gurdal C; Foster CS
Ophthalmology; 1999 Apr; 106(4):729-31. PubMed ID: 10201593
[TBL] [Abstract][Full Text] [Related]
7. Referral patterns, demographic and clinical features, and visual prognosis of Turkish patients with sarcoid uveitis.
Tugal-Tutkun I; Aydin-Akova Y; Güney-Tefekli E; Aynaci-Kahraman B
Ocul Immunol Inflamm; 2007; 15(4):337-43. PubMed ID: 17763132
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases.
Gonzalez-Gonzalez LA; Molina-Prat N; Doctor P; Tauber J; Sainz de la Maza MT; Foster CS
Ophthalmology; 2012 Jul; 119(7):1460-4. PubMed ID: 22463821
[TBL] [Abstract][Full Text] [Related]
9. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
Wieringa WG; Wieringa JE; ten Dam-van Loon NH; Los LI
Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
[TBL] [Abstract][Full Text] [Related]
10. Posterior scleritis in children: clinical features and treatment.
Cheung CM; Chee SP
Ophthalmology; 2012 Jan; 119(1):59-65. PubMed ID: 22137553
[TBL] [Abstract][Full Text] [Related]
11. Uveitis in Behçet disease: an analysis of 880 patients.
Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
[TBL] [Abstract][Full Text] [Related]
13. Nodular scleritis: case report involving immunosuppressive therapy.
Niemann KK; Bartlett JD; Heck LW; McCollum CJ
J Am Optom Assoc; 1997 Dec; 68(12):782-7. PubMed ID: 9635385
[TBL] [Abstract][Full Text] [Related]
14. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts].
Denk PO; Thiel HJ; Zierhut M
Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and presentation of posterior scleritis: a report of 31 cases.
Gonzalez-Gonzalez LA; Molina-Prat N; Doctor P; Tauber J; Sainz de la Maza M; Foster CS
Ocul Immunol Inflamm; 2014 Jun; 22(3):203-7. PubMed ID: 24131324
[TBL] [Abstract][Full Text] [Related]
16. Pattern of Scleritis in an Egyptian Cohort.
Abd El Latif E; Seleet MM; El Hennawi H; Abdulbadiea Rashed M; Elbarbary H; Sabry K; Abdelmonagy Ibrahim M
Ocul Immunol Inflamm; 2019; 27(6):890-896. PubMed ID: 30412434
[No Abstract] [Full Text] [Related]
17. Episcleritis and scleritis: clinical features and treatment results.
Jabs DA; Mudun A; Dunn JP; Marsh MJ
Am J Ophthalmol; 2000 Oct; 130(4):469-76. PubMed ID: 11024419
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
[TBL] [Abstract][Full Text] [Related]
19. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
20. [Scleritis, clinical features, etiologies and treatment: a case series of 32 patients].
Leal C; Le Roux K; Rahmi A; Varron L; Broussolle C; Denis P; Kodjikian L; Sève P
Rev Med Interne; 2014 Aug; 35(8):491-7. PubMed ID: 24210266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
